Insights

Circadian Therapeutics Small biopharma focused on circadian biology presents a target-rich opportunity for partner CROs, contract manufacturing, and specialized clinical trial services aligned with their efforts to discover and develop clock-modulating therapeutics.

Early-Stage Funding With 54M in funding and revenue under 1M, Reset Therapeutics is in a growth phase likely seeking strategic collaborations, licensing deals, and milestone-based partnerships to accelerate development and commercialization.

Limited Scale Small team size (11-50 employees) suggests high reliance on external collaborators for research, regulatory, manufacturing, and commercialization support; ideal for outsourced R&D partnerships and advisory services.

Digital Presence Active web and cloud-based tech footprint (AWS, Google Cloud, WordPress) indicates receptivity to digital marketing, cloud-enabled clinical operations, data management platforms, and scalable IT solutions as the company scales.

Market Positioning Focus on circadian-modulating therapies positions Reset within a large unmet need space spanning CNS, metabolic, cardiovascular, immune, and cancer domains, offering multiple collaboration lanes with pharma, biotech, and patient-support platforms.

Similar companies to Reset Therapeutics

Reset Therapeutics Tech Stack

Reset Therapeutics uses 8 technology products and services including Google AdSense, Amazon Web Services, WordPress, and more. Explore Reset Therapeutics's tech stack below.

Reset Therapeutics's Email Address Formats

Reset Therapeutics uses at least 2 email formats:
Reset Therapeutics Email FormatsExamplePercentage
First@resettherapeutics.comJohn@resettherapeutics.com
57%
FirstL@resettherapeutics.comJohnD@resettherapeutics.com
43%

Frequently Asked Questions

What is Reset Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Reset Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Reset Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Reset Therapeutics's official website is resettherapeutics.com and has social profiles on LinkedIn.

How much revenue does Reset Therapeutics generate?

Minus sign iconPlus sign icon
As of July 2026, Reset Therapeutics's annual revenue is estimated to be <$1M.

What is Reset Therapeutics's SIC code?

Minus sign iconPlus sign icon
Reset Therapeutics's SIC code is 8731 - Commercial Physical and Biological Research.

How many employees does Reset Therapeutics have currently?

Minus sign iconPlus sign icon
As of July 2026, Reset Therapeutics has approximately 16 employees across 1 continents, including North America. Key team members include Chief Financial Officer: S. K. Explore Reset Therapeutics's employee directory with LeadIQ.

What industry does Reset Therapeutics belong to?

Minus sign iconPlus sign icon
Reset Therapeutics operates in the Pharmaceuticals industry.

What technology does Reset Therapeutics use?

Minus sign iconPlus sign icon
Reset Therapeutics's tech stack includes Google AdSense, Amazon Web Services, WordPress, Twemoji, Google Cloud, Trustpilot, GoDaddy and Nginx.

What is Reset Therapeutics's email format?

Minus sign iconPlus sign icon
Reset Therapeutics's email format typically follows the pattern of First@resettherapeutics.com. Find more Reset Therapeutics email formats with LeadIQ.

How much funding has Reset Therapeutics raised to date?

Minus sign iconPlus sign icon
As of July 2026, Reset Therapeutics has raised $54M in funding. The last funding round occurred on Feb 19, 2016.
Reset Therapeutics logo

Reset Therapeutics

PharmaceuticalsCalifornia, United States11-50 Employees

Reset Therapeutics is a biopharmaceutical company focused on discovering, developing, and bringing to market therapies that influence the circadian system, the network of internal molecular clocks that regulate daily physiological rhythms. By modulating these rhythms, the company targets processes connected to light, activity, and nutrient status, including sleep, metabolism, blood pressure, and hormone secretion. Headquartered in South San Francisco, California, it operates within the pharmaceutical manufacturing sector. 

Its potential customers are patients affected by diseases linked to circadian disruption, including central nervous system disorders, cardiovascular and metabolic diseases, immune dysfunction, and cancer. Therapies that reset the body's biological clocks aim to address underlying mechanisms and could benefit large and diverse patient populations.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
Employees
11-50

Section iconFunding & Financials

  • $54M

    Reset Therapeutics has raised a total of $54M of funding over 3 rounds. Their latest funding round was raised on Feb 19, 2016 as a Venture Round.

  • <$1M

    Reset Therapeutics's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.